Drug
Aztreonam clinical trials
- studies test it
- 17
- open now
- 2
- in phase 3
- 10
- first study started
- 2008
Keep track of what changes. Save the Aztreonam studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Brand
Combined with it in one product
Studies by the year they started
17 studies that test it; most in 2011 (3)
| Year | Studies |
|---|---|
| 2008 | 2 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 3 |
| 2017 | 3 |
| 2019 | 2 |
| 2021 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 4
- Phase 3
- 10
- Phase 4
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 9 · Other 8
Gilead Sciences (8) · Karl Landsteiner Insitute for Nephrology and Haemato-Oncology (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · University of Washington (1) · Liverpool Heart and Chest Hospital NHS Foundation Trust (1) · Northwestern University (1) · Pfizer (1) · IRCCS Azienda Ospedaliero-Universitaria di Bologna (1)
Often tested with
Tested in the same studies.
Avibactam, ceftazidime drug combination (3) · Meropenem (2) · Imipenem (2) · Meropenem and vaborbactam (2) · Cefiderocol (2) · Eravacycline (2) · Tigecycline (2) · Ciprofloxacin (1)
Studies
Open first, then newest update. How each study uses Aztreonam is read from its arms, and is right about nine times in ten.
Testing it · 17
- Targeted Versus Standard Peri-operative Antibiotic Prophylaxis in Patients Colonized With Carbapenemase Producing Enterobacterales Undergoing Liver TransplantationNot yet recruitingPhase 3IRCCS Azienda Ospedaliero-Universitaria di BolognaNCT07759453Written as Aztreonam
- Optimising TREATment for Severe Gram-Negative Bacterial InfectionsRecruitingPhase 4National University of SingaporeNCT07004049Written as Ceftazidime-avibactam + Aztreonam
- Pharmacokinetics of Meropenem and Aztreonam After Intraperitoneal Administration Via Cycler-therapy in APD Patients Without PeritonitisCompletedPhase 2/3Karl Landsteiner Insitute for Nephrology and Haemato-OncologyNCT07113574Written as Aztreonam 2000 mg
- Study of Aztreonam for Inhalation in Children With Cystic Fibrosis and New Infection of the Airways by Pseudomonas Aeruginosa BacteriaTerminatedPhase 3Gilead SciencesNCT03219164Written as AZLI
- A Trial to Evaluate the Pharmacokinetics and Safety of AVYCAZ(R) in Combination With AztreonamCompletedPhase 1/2National Institute of Allergy and Infectious Diseases (NIAID)NCT03978091Written as AZACTAM
- Aztreonam for Pharyngeal GonorrheaCompletedPhase 2/3University of WashingtonNCT03867734Written as Aztreonam
- The Use of Inhaled Aztreonam in Children With a Tracheostomy Tube and PseudomonasTerminatedPhase 4UCSF Benioff Children's Hospital OaklandNCT03158116Written as Inhaled Aztreonam
- Aztreonam for Inhalation Solution (AZLI) for the Treatment of Exacerbations of Cystic FibrosisCompletedPhase 4Liverpool Heart and Chest Hospital NHS Foundation TrustNCT02894684Written as Aztreonam
- Antibiotic Prophylaxis for Transrectal Prostate BiopsyCompletedPhase 4Northwestern UniversityNCT01659866Written as aztreonam
- To Investigate the Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI)CompletedPhase 1PfizerNCT01689207Written as Aztreonam (ATM)
- Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CFCompletedPhase 3Gilead SciencesNCT01641822Written as AZLI
- Safety of AZLI in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa in the Lower AirwaysCompletedPhase 3Gilead SciencesNCT01404234Written as AZLI
- Safety and Effectiveness of AZLI (an Inhaled Antibiotic) in Adults With Non-Cystic Fibrosis BronchiectasisCompletedPhase 3Gilead SciencesNCT01314716Written as AZLI
- Safety and Effectiveness of AZLI (an Inhaled Antibiotic) in Adults With Non-Cystic Fibrosis BronchiectasisCompletedPhase 3Gilead SciencesNCT01313624Written as AZLI
- Evaluation of the Quality of Life Questionnaire-Bronchiectasis (QOL-B) in Patients With BronchiectasisCompletedPhase 2Gilead SciencesNCT00805025Written as AZLI
- Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Patients With Cystic Fibrosis and Chronic Burkholderia Species InfectionCompletedPhase 3Gilead SciencesNCT01059565Written as AZLI
- Aztreonam for Inhalation Solution vs Tobramycin Inhalation Solution in Patients With Cystic Fibrosis & Pseudomonas AeruginosaCompletedPhase 3Gilead SciencesNCT00757237Written as Aztreonam for Inhalation Solution (AZLI)
Given in every arm · 3 — Aztreonam is usual care beside what is tested
- Aztreonam Aerosol to Treat Cystic Fibrosis Nasal DiseaseTerminatedPhase 2Virginia Commonwealth UniversityNCT02730793Written as Oral Aztreonam
- Study of Tedizolid Phosphate in Adolescents With Complicated Skin and Soft Tissue Infection (cSSTI) (MK-1986-012)CompletedPhase 3Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)NCT02276482Written as Aztreonam
- Phase 1 Study to Evaluate DDI, PK, Safety, Tolerability of SPR741CompletedPhase 1Spero TherapeuticsNCT03376529Written as Aztreonam
As the comparator · 8 — what is tested is compared with Aztreonam
- Ceftobiprole in the Treatment of Patients With Acute Bacterial Skin and Skin Structure InfectionsCompletedPhase 3Basilea PharmaceuticaNCT03137173Written as vancomycin+aztreonam
- Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure InfectionsCompletedPhase 3Melinta Therapeutics, Inc.NCT01984684Written as aztreonam
- Delafloxacin Versus Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure InfectionsCompletedPhase 3Melinta Therapeutics, Inc.NCT01811732Written as Aztreonam
- Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin InfectionsCompletedPhase 3PfizerNCT01499277Written as Aztreonam
- Evaluation of Ceftaroline Fosamil vs Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections.TerminatedPhase 3PfizerNCT02202135Written as Aztreonam
- Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin InfectionsCompletedPhase 3Forest LaboratoriesNCT00423657Written as vancomycin plus aztreonam
- Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin InfectionsCompletedPhase 3Forest LaboratoriesNCT00424190Written as IV Vancomycin plus IV Aztreonam
- Efficacy and Safety of Ceftaroline Versus Linezolid in Subjects With Complicated Skin and Skin Structure InfectionsCompletedPhase 2Forest LaboratoriesNCT00633152Written as Aztreonam
Codes
What other systems call Aztreonam · ClinicalTrials.gg INT007041
- MeSH (NLM) D001398AztreonamConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) G2B4VE5GH8AZTREONAMConfirmed FDA, NLM, Wikidata
- RxNorm 1272Confirmed FDA, Wikidata
- Wikidata Q418546aztreonamConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C28845AztreonamOne source FDA
- DrugBank DB00355One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D001398 | Aztreonam | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | G2B4VE5GH8 | AZTREONAM | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1272 | — | Confirmed FDA, Wikidata |
| Wikidata | Q418546 | aztreonam | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C28845 | Aztreonam | One source FDA |
| DrugBank | DB00355 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.